UPS has announced collaboration with Dr. Reddy’s Laboratories to get 30 tonnes of pharmaceuticals from India to the United States via Europe. The sensitive cargo had to be shipped within a controlled temperature range to ensure product stability. Given the supply chain challenges and restrictions due to the Coronavirus pandemic, UPS Healthcare and Dr. Reddy’s created an emergency supply chain plan to replenish pharmaceutical stocks in US markets.

“During this pandemic, moving critical controlled room temperature medicines requires extra planning given the air market capacity demand levels,” said Wes Wheeler, president of UPS Healthcare. “We are providing compliant storage, transit and customs clearance expertise to help ensure products move quickly and retain their efficacy. This collaboration enabled Dr. Reddy’s to replenish its stocks in US locations and provide essential medicines to meet demand.”

The time-critical flight originated in Hyderabad, India, moved through UPS’s European air hub in Cologne, Germany, and continued to the UPS Worldport air hub in Louisville, Kentucky. UPS works closely with international customs and authorities and will continue to deliver essential medicines and goods to help support the battle against the global Coronavirus pandemic.

“Dr. Reddy’s Laboratories aims to ensure that essential medicines are within reach of patients by maintaining an uninterrupted supply globally. Our commitment to ensure accelerated access to affordable and innovative medicines to millions of patients around the world, holds significance more than ever in the present times,” said Puvvala Yugandhar, head of global supply chain, Dr. Reddy’s Laboratories. “In this critical situation of the disruption caused by the Coronavirus, we connected with the UPS Healthcare team who helped ensure that critical medicines reach pharmacies and hospitals in the US on time for patients.”